HTCO News 12.47 Hickory Tech Corp (HTCO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hickory Tech Corp (HTCO) 12.47 $HTCO

HickoryTech to Report First Quarter 2014 Earnings on May 1
Business Wire - Mon Apr 07, 12:28PM CDT
HickoryTech Corporation (NASDAQ: HTCO), a leading communications solution provider, will release its first quarter 2014 results on Thursday, May 1 after the market closes. The company will discuss its results in a conference call on Friday, May 2 at 9 a.m. CT via dial-in number 877-372-0867 for U.S. and Canadian callers, conference ID 20839064.

HickoryTech's board declares USD0.15 quarterly cash dividend
M2 - Wed Mar 12, 8:15AM CDT
Communications provider HickoryTech Corporation (Nasdaq:HTCO) announced on Tuesday the declaration by its board of directors of a quarterly dividend of USD0.15 per share of HickoryTech common stock.

HickoryTech Declares Quarterly Cash Dividend
Business Wire - Tue Mar 11, 12:00PM CDT
HickoryTech Corporation (NASDAQ: HTCO) today announced its Board of Directors voted to declare a quarterly dividend of $0.15 per share of HickoryTech common stock. The $0.15 dividend is payable in the second quarter on June 5, 2014 to shareholders of record on May 15, 2014.

HickoryTech Reports Fourth Quarter and Fiscal 2013 Results
Business Wire - Mon Mar 03, 3:18PM CST
--Full year EBITDA grew 2 percent to $47 million

HickoryTech to Present at Deutsche Bank Annual Media, Internet & Telecom Conference on March 10, 2014
Business Wire - Wed Feb 26, 3:53PM CST
HickoryTech Corporation (NASDAQ: HTCO) announced today that it will present at Deutsche Bank's 22nd Annual Media, Internet & Telecom Conference in Palm Beach, Fla. on Monday, March 10, 2014.

Research and Markets: EU5 Orthopedic Braces and Supports Market Outlook to 2020 - Research Report
Business Wire - Thu Feb 13, 3:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/td7ksj/eu5_orthopedic) has announced the addition of the "EU5 Orthopedic Braces and Supports Market Outlook to 2020" report to their offering.

HickoryTech to Report Fourth Quarter 2013 Results on March 3
Business Wire - Tue Feb 11, 8:46AM CST
HickoryTech Corporation (NASDAQ: HTCO), a leading communications solution provider, will release its fourth quarter 2013 results on Monday, March 3 after the market closes. The company will discuss its results in a conference call on Tuesday, March 4 at 9 a.m. CT via dial-in number 877-372-0867 for U.S. and Canadian callers, conference ID 59515217.

Enventis Achieves Cisco Master Cloud Builder Specialization
GlobeNewswire - Wed Feb 05, 3:58PM CST
Enventis (Nasdaq:HTCO) announced today that it has achieved the Cisco Master Cloud Builder Specialization. This specialization recognizes Enventis as having the capabilities to build and deploy cloud-ready integrated infrastructures based on Cisco solutions and technology ecosystem partner cloud offerings across storage, virtualization, cloud management and virtual desktop.

HickoryTech announces dividend of USD0.15 per share for quarter
M2 - Wed Jan 29, 5:29AM CST
The board of directors of US-based communications provider, HickoryTech Corporation (NASDAQ:HTCO) approved a quarterly common share dividend of USD0.15 per share, the company revealed on Tuesday.

Acacia's subsidiary signs settlement and patent license agreement With HickoryTech Corporation
M2 - Mon Jan 06, 5:33AM CST
Patent licensing company Acacia Research Corporation (Nasdaq:ACTG) announced on Friday that its subsidiary, Brandywine Communications Technologies LLC, has entered into a settlement and patent license agreement with HickoryTech Corporation.

Acacia Subsidiary Enters Into Settlement and Patent License Agreement With HickoryTech Corporation
Business Wire - Fri Jan 03, 5:00AM CST
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Brandywine Communications Technologies, LLC subsidiary has entered into a settlement and patent license agreement with HickoryTech Corporation. The agreement resolves litigation that was pending in the United States District Court for the District of Minnesota.

Uptrend Call Working As HickoryTech Stock Rises 15.0% (HTCO)
Comtex SmarTrend(R) - Fri Dec 27, 5:09PM CST
SmarTrend identified an Uptrend for HickoryTech (NASDAQ:HTCO) on September 25th, 2013 at $11.27. In approximately 3 months, HickoryTech has returned 15.05% as of today's recent price of $12.96.

Shares of HTCO Up 15.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Dec 17, 11:20AM CST
SmarTrend identified an Uptrend for HickoryTech (NASDAQ:HTCO) on September 25th, 2013 at $11.27. In approximately 3 months, HickoryTech has returned 15.67% as of today's recent price of $13.03.

HickoryTech Up 21.5% Since SmarTrend Uptrend Call (HTCO)
Comtex SmarTrend(R) - Mon Dec 02, 10:00AM CST
SmarTrend identified an Uptrend for HickoryTech (NASDAQ:HTCO) on September 25th, 2013 at $11.27. In approximately 2 months, HickoryTech has returned 21.47% as of today's recent price of $13.68.

HickoryTech Shares Up 17.8% Since SmarTrend's Buy Recommendation (HTCO)
Comtex SmarTrend(R) - Mon Nov 25, 9:53AM CST
SmarTrend identified an Uptrend for HickoryTech (NASDAQ:HTCO) on September 25th, 2013 at $11.27. In approximately 2 months, HickoryTech has returned 17.80% as of today's recent price of $13.27.

HickoryTech Reports Third Quarter 2013 Results
Business Wire - Mon Nov 04, 3:06PM CST
--Fiber and Data revenue increased 8%

HickoryTech signs amended debt financing agreement for USD165m
M2 - Thu Oct 31, 6:13AM CDT
Communications provider HickoryTech Corporation (NASDAQ:HTCO), doing business as Enventis, has closed its debt refinancing agreement for an aggregate credit facility of USD165m, it stated on Wednesday.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 513

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Applied Materials: Navigating Earnings Signals and Market Trends

Updated Category News Views 180

Applied Materials: What's Ahead for Investors? Applied Materials Inc has emerged as one of the most prominent performers in the stock market lately. With shares showing an impressive increase of 26% year-to-date and an astounding 170% rise since the previous spring, investors are buzzing about its success and future. This surge has garnered attention, especially as the...

Continue Reading
Transforming Money for the Digital Age with Lightspark

Updated Category News Views 363

Reimagining Financial Transactions with Lightspark Lightspark launched with a vision to revolutionize the way we perceive and use money, aiming to cultivate a future where financial interactions mirror the rapid connectivity of the internet. With the burgeoning demand for swift, borderless, and seamless value transfer, it's imperative that financial infrastructures evolve...

Continue Reading
XploraDEX Token Launch Sets New Stage for DeFi Innovation

Updated Category News Views 184

Exciting News from XploraDEX's Ecosystem In a remarkable development, the XploraDEX ecosystem has officially initiated the distribution of the highly anticipated $XPL Token. This signifies a pivotal transition from the fundraising phase to a more active operational state. As part of the early rollout, initial investors are beginning to receive their tokens, marking a...

Continue Reading
Empire Development Unveils Luxurious Real Estate Offerings

Updated Category News Views 253

Empire Development Unveils Gorgeous New Properties Empire Development is excited to share the addition of three stunning properties to its luxury real estate collection. These remarkable homes, exclusively listed by the Senada Adzem Team of Douglas Elliman Real Estate, reflect the company’s dedication to redefining luxury in today’s market. Discovering Outstanding...

Continue Reading
Biden's Final Moves: Key Actions Before Transitioning Power

Updated Category News Views 169

Biden's Urgent Priorities Before the Transition As President Joe Biden approaches the end of his term, he faces an extensive list of foreign and domestic challenges he aims to address. With the impending transition to president-elect Donald Trump, whose administration is anticipated to overturn much of Biden's work, the urgency to act has increased significantly. Foreign...

Continue Reading